Combination of Simvastatin and Metformin Reduces Triple‐Negative Breast Cancer Tumor Growth Through AKT/AMPK/ACC Signaling Axis
Year: 2025
Type: article
Source: Molecular Carcinogenesis
DOI: 10.1002/mc.70056
Authors: Santosh Kumar Maurya, Shashank Kumar
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415378722
